Lesson 3 • 22 Jan 2025
Patient characteristics and decision-making for liver surgery versus transplant in HCC
Course overview
This course highlights collaborative approaches to HCC management, covering surgical strategies including downstaging, transplant perspectives from surgeons and hepatologists, and multidisciplinary tumor board insights on managing disease progression through case reviews. The course is supported by an educational grant from AstraZeneca, with additional support from Boston Scientific.
To earn CME/CE credits for this course, it must be completed on the BackTable+ website.
2 CME/CE credits, 2 hours, 22 lessons
Lessons
Surgical Approach to HCC (Where Does Downstaging Fit)
Lesson 1
Define curative care and palliative care
Lesson 2
Liver resection types, and patient considerations for transplant and surgical procedures
Lesson 3
Patient characteristics and decision-making for liver surgery versus transplant in HCC
Lesson 4
Transplant criteria, exception points, and living donor benefits
Lesson 5
Surgical versus minimally invasive options for HCC treatment, including the role of robotics
Lesson 6
Difficulties and techniques in liver surgeries post-Y90 radioembolization, including scar tissue
Lesson 7
Communication challenges and solutions between community doctors and transplant centers
Transplant Approach from the Transplant Surgeon & Hepatologist
Lesson 8
Lesson 9
Support networks, patient selection, and the approval process in transplant procedures
Lesson 10
The liver transplant process, MELD scoring, and anticoagulation strategies for transplant patients
Lesson 11
Transplant timing, risks, and considerations for portal vein recanalization
Lesson 12
Lesson 13
Peri-transplant experiences, new technologies, donor types, and organ acceptance practices
Lesson 14
Post-transplant complications, immunosuppression, and management of rejection after liver transplant
Tumor Board Collaboration: Disease Progression (Case Review)
Lesson 15
Case 1: Surgical and non-surgical treatments for a 60-year-old with solitary LR5
Lesson 16
Case 2: 68 yr old non-cirrhotic patient with a LR-5 HCC lesion
Lesson 17
Case 3: Multifocal HCC in a non-cirrhotic patient
Lesson 18
Case 4: 67 year old with cirrhosis, pHTN, and 10 cm HCC
Lesson 19
Case 5: 78-year-old male with ruptured HCC
Lesson 20
Case 6: 64 yr old with multifocal HCC, considerations include immunotherapy and potential transplant
Lesson 21
Case 7: Treatment strategies for a 61-year-old male with HCC and portal vein involvement
Lesson 22
Case 8: 78 yr old with HCC, presents post transplant with adrenal met
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.